VRDN logo

Viridian Therapeutics, Inc. (VRDN) CAPEX

Annual CAPEX:

$511.00K-$387.00K(-43.10%)
December 31, 2024

Summary

  • As of today, VRDN annual capital expenditures is $511.00 thousand, with the most recent change of -$387.00 thousand (-43.10%) on December 31, 2024.
  • During the last 3 years, VRDN annual CAPEX has risen by +$173.00 thousand (+51.18%).
  • VRDN annual CAPEX is now -43.10% below its all-time high of $898.00 thousand, reached on December 31, 2023.

Performance

VRDN CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRDNcash flow metrics

Quarterly CAPEX:

$42.00K-$44.00K(-51.16%)
June 30, 2025

Summary

  • As of today, VRDN quarterly capital expenditures is $42.00 thousand, with the most recent change of -$44.00 thousand (-51.16%) on June 30, 2025.
  • Over the past year, VRDN quarterly CAPEX has dropped by -$62.00 thousand (-59.62%).
  • VRDN quarterly CAPEX is now -89.60% below its all-time high of $404.00 thousand, reached on September 30, 2023.

Performance

VRDN Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRDNcash flow metrics

TTM CAPEX:

$535.00K-$62.00K(-10.39%)
June 30, 2025

Summary

  • As of today, VRDN TTM capital expenditures is $535.00 thousand, with the most recent change of -$62.00 thousand (-10.39%) on June 30, 2025.
  • Over the past year, VRDN TTM CAPEX has dropped by -$21.00 thousand (-3.78%).
  • VRDN TTM CAPEX is now -40.42% below its all-time high of $898.00 thousand, reached on December 31, 2023.

Performance

VRDN TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRDNcash flow metrics

VRDN CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-43.1%-59.6%-3.8%
3Y3 Years+51.2%-85.6%-27.7%
5Y5 Years+508.3%+100.0%+909.4%

VRDN CAPEX Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-43.1%+51.2%-89.6%>+9999.0%-40.4%+31.4%
5Y5-Year-43.1%+1116.7%-89.6%>+9999.0%-40.4%+909.4%
All-TimeAll-Time-43.1%>+9999.0%-89.6%>+9999.0%-40.4%>+9999.0%

VRDN CAPEX History

DateAnnualQuarterlyTTM
Jun 2025
-
$42.00K(-51.2%)
$535.00K(-10.4%)
Mar 2025
-
$86.00K(-24.6%)
$597.00K(+16.8%)
Dec 2024
$511.00K(-43.1%)
$114.00K(-61.1%)
$511.00K(+14.8%)
Sep 2024
-
$293.00K(+181.7%)
$445.00K(-20.0%)
Jun 2024
-
$104.00K(>+9900.0%)
$556.00K(-29.0%)
Mar 2024
-
$0.00(-100.0%)
$783.00K(-12.8%)
Dec 2023
$898.00K(+12.7%)
$48.00K(-88.1%)
$898.00K(+5.6%)
Sep 2023
-
$404.00K(+22.1%)
$850.00K(+90.6%)
Jun 2023
-
$331.00K(+187.8%)
$446.00K(+9.6%)
Mar 2023
-
$115.00K(-60.6%)
$407.00K(-45.0%)
Dec 2022
$797.00K(+135.8%)
-
-
Jun 2022
-
$292.00K(+63.1%)
$740.00K(+47.4%)
Mar 2022
-
$179.00K(+113.1%)
$502.00K(+48.5%)
Dec 2021
$338.00K(+704.8%)
$84.00K(-54.6%)
$338.00K(+27.5%)
Sep 2021
-
$185.00K(+242.6%)
$265.00K(+99.2%)
Jun 2021
-
$54.00K(+260.0%)
$133.00K(+68.4%)
Mar 2021
-
$15.00K(+36.4%)
$79.00K(+23.4%)
Dec 2020
$42.00K(-50.0%)
$11.00K(-79.2%)
$64.00K(+20.8%)
Sep 2020
-
$53.00K(>+9900.0%)
$53.00K(+253.3%)
Jun 2020
-
$0.00(0.0%)
$15.00K(-68.1%)
Mar 2020
-
$0.00(0.0%)
$47.00K(-44.0%)
Dec 2019
$84.00K
$0.00(-100.0%)
$84.00K(-37.8%)
Sep 2019
-
$15.00K(-53.1%)
$135.00K(-58.5%)
DateAnnualQuarterlyTTM
Jun 2019
-
$32.00K(-13.5%)
$325.00K(-16.0%)
Mar 2019
-
$37.00K(-27.5%)
$387.00K(-13.0%)
Dec 2018
$445.00K(+80.9%)
$51.00K(-75.1%)
$445.00K(+4.0%)
Sep 2018
-
$205.00K(+118.1%)
$428.00K(+49.7%)
Jun 2018
-
$94.00K(-1.1%)
$286.00K(-3.7%)
Mar 2018
-
$95.00K(+179.4%)
$297.00K(+20.7%)
Dec 2017
$246.00K(+8100.0%)
$34.00K(-46.0%)
$246.00K(+10.8%)
Sep 2017
-
$63.00K(-40.0%)
$222.00K(-43.9%)
Jun 2017
-
$105.00K(+138.6%)
$396.00K(+36.1%)
Mar 2017
-
$44.00K(+340.0%)
$291.00K(+16.4%)
Dec 2016
$3000.00(-97.6%)
$10.00K(-95.8%)
$250.00K(-4.9%)
Sep 2016
-
$237.00K(>+9900.0%)
$263.00K(+353.4%)
Jun 2016
-
$0.00(-100.0%)
$58.00K(-29.3%)
Mar 2016
-
$3000.00(-87.0%)
$82.00K(-33.3%)
Dec 2015
$123.00K(-53.8%)
$23.00K(-28.1%)
$123.00K(-66.0%)
Sep 2015
-
$32.00K(+33.3%)
$361.70K(+9.7%)
Jun 2015
-
$24.00K(-45.5%)
$329.70K(+7.9%)
Mar 2015
-
$44.00K(-83.2%)
$305.70K(+16.8%)
Dec 2014
$266.00K(+5220.0%)
$261.70K(>+9900.0%)
$261.70K(>+9900.0%)
Sep 2014
-
$0.00(-100.0%)
$2600.00(0.0%)
Dec 2013
$5000.00(-95.3%)
$2600.00(>+9900.0%)
$2600.00(>+9900.0%)
Dec 2012
$106.90K
-
-
Dec 2012
-
$0.00
$0.00

FAQ

  • What is Viridian Therapeutics, Inc. annual capital expenditures?
  • What is the all-time high annual CAPEX for Viridian Therapeutics, Inc.?
  • What is Viridian Therapeutics, Inc. annual CAPEX year-on-year change?
  • What is Viridian Therapeutics, Inc. quarterly capital expenditures?
  • What is the all-time high quarterly CAPEX for Viridian Therapeutics, Inc.?
  • What is Viridian Therapeutics, Inc. quarterly CAPEX year-on-year change?
  • What is Viridian Therapeutics, Inc. TTM capital expenditures?
  • What is the all-time high TTM CAPEX for Viridian Therapeutics, Inc.?
  • What is Viridian Therapeutics, Inc. TTM CAPEX year-on-year change?

What is Viridian Therapeutics, Inc. annual capital expenditures?

The current annual CAPEX of VRDN is $511.00K

What is the all-time high annual CAPEX for Viridian Therapeutics, Inc.?

Viridian Therapeutics, Inc. all-time high annual capital expenditures is $898.00K

What is Viridian Therapeutics, Inc. annual CAPEX year-on-year change?

Over the past year, VRDN annual capital expenditures has changed by -$387.00K (-43.10%)

What is Viridian Therapeutics, Inc. quarterly capital expenditures?

The current quarterly CAPEX of VRDN is $42.00K

What is the all-time high quarterly CAPEX for Viridian Therapeutics, Inc.?

Viridian Therapeutics, Inc. all-time high quarterly capital expenditures is $404.00K

What is Viridian Therapeutics, Inc. quarterly CAPEX year-on-year change?

Over the past year, VRDN quarterly capital expenditures has changed by -$62.00K (-59.62%)

What is Viridian Therapeutics, Inc. TTM capital expenditures?

The current TTM CAPEX of VRDN is $535.00K

What is the all-time high TTM CAPEX for Viridian Therapeutics, Inc.?

Viridian Therapeutics, Inc. all-time high TTM capital expenditures is $898.00K

What is Viridian Therapeutics, Inc. TTM CAPEX year-on-year change?

Over the past year, VRDN TTM capital expenditures has changed by -$21.00K (-3.78%)
On this page